The DOI matches its Crossref record.
Gamma-globulin treatment of acute myocarditis in the pediatric population.
Abstract
BACKGROUND: Myocardial damage in myocarditis is mediated, in part, by immunological mechanisms. High-dose intravenous gamma-globulin (IVIG) is an immunomodulatory agent that is beneficial in myocarditis secondary to Kawasaki disease, as well as in murine myocarditis. Since 1990, the routine management of presumed acute myocarditis at Children's Hospital, Boston, and Children's Hospital, Los Angeles, has included administration of high-dose IVIG. METHODS AND RESULTS: We treated 21 consecutive children presenting with presumed acute myocarditis with IVIG, 2 g/kg, over 24 hours, in addition to anticongestive therapies. A comparison group comprised 25 recent historical control patients meeting identical eligibility criteria but not receiving IVIG therapy. Left ventricular function was assessed during five time intervals: 0 to 7 days, 1 to 3 weeks, 3 weeks to 3 months, 3 to 6 months, and 6 to 12 months. At presentation, the IVIG and non-IVIG groups had comparable left ventricular enlargement and poor fractional shortening. Compared with the non-IVIG group, those treated with IVIG had a smaller mean adjusted left ventricular end-diastolic dimension and higher fractional shortening in the periods from 3 to 6 months (P = .008 and P = .033, respectively) and 6 to 12 months (P = .072 and P = .029, respectively). When adjusting for age, biopsy status, intravenous inotropic agents, and angiotensin-converting enzyme inhibitors, patients treated with IVIG were more likely to achieve normal left ventricular function during the first year after presentation (P = .03). By 1 year after presentation, the probability of survival tended to be higher among IVIG-treated patients (.84 versus .60, P = .069). We observed no adverse effects of IVIG administration. CONCLUSIONS: These data suggest that use of high-dose IVIG for treatment of acute myocarditis is associated with improved recovery of left ventricular function and with a tendency to better survival during the first year after presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,318
Feldman, A. M., & McNamara, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 958
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007405 · Cited by 811
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Viral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
ORANGE, J., HOSSNY, E., WEILER, C., BALLOW, M., BERGER, M., BONILLA, F., BUCKLEY, R., CHINEN, J., ELGAMAL, Y., & MAZER, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.015 · Cited by 653
Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 649
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre-Amione, G., Gass, A., Janosko, K., Tokarczyk, T., Kessler, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2254 · Cited by 560
Kawai, C. (1999) · Circulation · doi:10.1161/01.cir.99.8.1091 · Cited by 552
Advances in the Understanding of Myocarditis
Liu, P. P., & Mason, J. W. (2001) · Circulation · doi:10.1161/hc3401.095198 · Cited by 494
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Lee, P. Y., Day-Lewis, M., Henderson, L. A., Friedman, K. G., Lo, J., Roberts, J. E., Lo, M. S., Platt, C. D., Chou, J., Hoyt, K. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141113 · Cited by 396
Self-citationSperotto, F., Friedman, K. G., Son, M. B. F., VanderPluym, C. J., Newburger, J. W., & Dionne, A. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-020-03766-6 · Cited by 385
Self-citationDaubeney, P. E. F., Nugent, A. W., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C. W., & Weintraub, R. G. (2006) · Circulation · doi:10.1161/circulationaha.106.635128 · Cited by 382
Self-citationBlauwet, L. A., & Cooper, L. T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.006 · Cited by 374
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure
Gullestad, L., Aass, H., Fjeld, J. G., Wikeby, L., Andreassen, A. K., Ihlen, H., Simonsen, S., Kjekshus, J., Nitter-Hauge, S., Ueland, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.220 · Cited by 349
Law, Y. M., Lal, A. K., Chen, S., Čiháková, D., Cooper, L. T., Deshpande, S., Godown, J., Grosse-Wortmann, L., Robinson, J. D., Towbin, J. A., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001001 · Cited by 340
Heart Failure Society Of America (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91340-4 · Cited by 336
Schultheiss, H.-P., Kuhl, U., & Cooper, L. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr165 · Cited by 301
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis
Ammirati, E., Cipriani, M., Lilliu, M., Sormani, P., Varrenti, M., Raineri, C., Petrella, D., Garascia, A., Pedrotti, P., Roghi, A., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.026386 · Cited by 292
Inflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289
Kantor, P. F., Lougheed, J., Dancea, A., McGillion, M., Barbosa, N., Chan, C., Dillenburg, R., Atallah, J., Buchholz, H., Chant-Gambacort, C., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.08.008 · Cited by 267
Mechanical circulatory support for the treatment of children with acute fulminant myocarditis
Duncan, B. W., Bohn, D. J., Atz, A. M., French, J. W., Laussen, P. C., & Wessel, D. L. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.115243 · Cited by 260
Self-citationDiagnosis and Treatment of Myocarditis in Children in the Current Era
Canter, C. E., & Simpson, K. E. (2014) · Circulation · doi:10.1161/circulationaha.113.001372 · Cited by 259
Metadata
- Authors
- Drucker, N. A., Colan, S. D., Lewis, A. B., Beiser, A. S., Wessel, D. L., Takahashi, M., Baker, A. L., Perez-Atayde, A. R., & Newburger, J. W.
- Venue
- Circulation
- Published
- 1994-01
- Volume
- 89
- Issue
- 1
- Pages
- 252-257
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1996110848
- Cited by
- 436
- References
- 0
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.